CLABSI Prevention With Tissue Adhesive

Recruiting now · Not applicable

Conditions studied: Central-line Associated Blood Stream Infections (CLABSI)

In brief

Our aim is to test the effect of tissue adhesive application at the Central-line exit-site on CLABSI rates in high-risk pediatric congenital heart disease patients.

Key facts

Study ID

NCT05721677

Run by

Rabin Medical Center

People needed

600

Starts

2023-03-15

Expected to finish

2026-09-15

Last updated by the study team

2024-10-02

Who can join

Age: any, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All patients admitted to pediatric cardiac ICU (PCICU) defined as high-risk for CLABSI (any of):
• young age<1y \& Congenital Heart Surgery Mortality Category (STAT\\STS-EACTS) score 2-5
• Risk Adjustment for Congenital Heart Surgery (RACHS) category ≥3
• preoperative length-of-stay (LOS) >7 days
• preoperative ventilator support
• presence of a genetic abnormality
• extracorporeal membrane oxygenation (ECMO) support

You may not qualify if…

• Patients with on-going bacteremia
• patients with pre-existing central-line or peripherally inserted central catheter (PICC)
• parental refusal to participate.

Where it is running

• Schneider's children medical center — Petah Tikva, Israel (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.